BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18808419)

  • 1. Incidence of primary cutaneous T-cell lymphoma in Norway.
    Saunes M; Nilsen TI; Johannesen TB
    Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
    Arai E; Katayama I; Ishihara K
    Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
    Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
    JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
    Vij A; Duvic M
    Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome.
    Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S
    Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
    Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
    J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome.
    Bi MY; Curry JL; Christiano AM; Hordinsky MK; Norris DA; Price VH; Duvic M
    J Am Acad Dermatol; 2011 Jan; 64(1):53-63. PubMed ID: 21036417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycosis fungoides and Sezary syndrome against a human immunodeficiency virus-positive background: case report.
    Gahongayire F
    Int J Dermatol; 2007 Oct; 46 Suppl 1():32-5. PubMed ID: 17919204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides and Sézary syndrome: a population-wide study on prevalence and health care use in Finland in 1998-2016.
    Keto J; Hahtola S; Linna M; Väkevä L
    BMC Health Serv Res; 2021 Feb; 21(1):166. PubMed ID: 33618714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.
    Pruksaeakanan C; Teyateeti P; Patthamalai P; Thumrongtharadol J; Chairatchaneeboon M
    Biomed Res Int; 2021; 2021():4057661. PubMed ID: 34235215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence rate of mycosis fungoides in Isfahan (Iran).
    Salehi M; Azimi Z; Fatemi F; Rajabi P; Kazemi M; Amini G
    J Dermatol; 2010 Aug; 37(8):703-7. PubMed ID: 20649711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
    Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
    Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous lymphomas.
    Smith BD; Wilson LD
    Semin Radiat Oncol; 2007 Jul; 17(3):158-68. PubMed ID: 17591562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus: its potential role in the development of cutaneous T-cell lymphoma.
    Ballanger F; Bressollette C; Volteau C; Planche L; Dreno B
    Exp Dermatol; 2009 Jun; 18(6):574-6. PubMed ID: 19320742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous lymphoma in Argentina: a report of a nationwide study of 416 patients.
    Abeldaño A; Enz P; Maskin M; Cervini AB; Torres N; Acosta AC; Narbaitz M; Vanzulli S; Orentrajch M; Villareal MA; Garcia Pazos ML; Arias M; Zambrano Franco EA; Fontana MI; Chuit R
    Int J Dermatol; 2019 Apr; 58(4):449-455. PubMed ID: 30294921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
    Tan ES; Tang MB; Tan SH
    Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.